Singapore - English - HSA (Health Sciences Authority)

dksh singapore pte. ltd. - fusidic acid; hydrocortisone acetate - cream - 20 mg/g - fusidic acid 20 mg/g; hydrocortisone acetate 10 mg/g

Singapore - English - HSA (Health Sciences Authority)

dksh singapore pte. ltd. - fusidic acid - cream - 20 mg/g - fusidic acid 20 mg/g

Malta - English - Medicines Authority

merz pharmaceuticals gmbh eckenheimer landstrasse 100, d-60318 frankfurt am main, germany - heparin sodium, extractum cepae, allantoin - gel - heparin sodium 5000 iu extractum cepae 10 g allantoin 1 g - preparations for treatment of wounds and ulcers

Australia - English - Department of Health (Therapeutic Goods Administration)

bausch & lomb australia pty ltd - 47841 - soft corrective contact lens, daily-disposable - a soft ophthalmic lens indicated for the daily wear correction of refractive ametropia (myopia, hyperopia, and astigmatism). the lens is to be prescribed for single-use disposable wear, and is to be discarded after each wearing period. the device may be cosmetically tinted to change the appearance of the eye for cosmetic purposes.

United States - English - NLM (National Library of Medicine)

par pharmaceutical, inc. - pimozide (unii: 1hiz4dl86f) (pimozide - unii:1hiz4dl86f) - pimozide 1 mg - pimozide tablets, usp is indicated for the suppression of motor and phonic tics in patients with tourette’s disorder who have failed to respond satisfactorily to standard treatment. pimozide tablets, usp is not intended as a treatment of first choice nor is it intended for the treatment of tics that are merely annoying or cosmetically troublesome. pimozide tablets, usp should be reserved for use in tourette’s disorder patients whose development and/or daily life function is severely compromised by the presence of motor and phonic tics. evidence supporting approval of pimozide tablets, usp for use in tourette’s disorder was obtained in two controlled clinical investigations which enrolled patients between the ages of 8 and 53 years. most subjects in the two trials were 12 or older. 1. pimozide is contraindicated in the treatment of simple tics or tics other than those associated with tourette’s disorder. 2. pimozide should not be used in patients taking drugs that may, themselves, cause motor and phonic tics (

United States - English - NLM (National Library of Medicine)

allure labs, inc. - zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - zinc oxide 95 mg in 1 ml - optimal for daily use, this state-of-the-art, broad-spectrum sunscreen contains zinc oxide to help protect against the damaging effects of uva and uvb rays. cosmetically elegant and hydrating, this sunscreen id rapidly absorbed into the skin and is ideal for acne-prone akin and post-professional treatments.

United States - English - NLM (National Library of Medicine)

allure labs, inc. - zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - zinc oxide 95 mg in 1 ml - optimal for daily use, this state-of-the-art lotion contains zinc oxide to help protect against the damaging effects of uva and uvb rays. cosmetically elegant and hydrating, this lotion id ideal for sensitive skin and post professional treatments. directions: apply daily to the fingertips and gently massage into the skin. reapply as needed. discontinue use if irritation develops.

Australia - English - Department of Health (Therapeutic Goods Administration)

intermed medical pty ltd - sodium tetradecyl sulfate, quantity: 10 mg/ml - injection, solution - excipient ingredients: benzyl alcohol; dibasic sodium phosphate dodecahydrate; monobasic potassium phosphate; water for injections; sodium hydroxide - the solution is designed for injection directly into the lumen of the varicose vein and is used as a sclerosant in the treatment of uncomplicated varicose veins of the leg by compression sclerotherapy. the strength of fibrovein selected depends on the size of the veins to be treated. fibrovein 3% is for the treatment of large superficial varicose veins. fibrovein 1% is for the treatment of small varicose veins and the larger venules. minor venules and spider veins (venous flares) should be treated with fibrovein 0.5% or 0.2%. the selection of the incorrect strength particularly in the case of minor venules and spider veins is liable to give risk to adverse reactions.

Australia - English - Department of Health (Therapeutic Goods Administration)

intermed medical pty ltd - sodium tetradecyl sulfate, quantity: 2 mg/ml - injection, solution - excipient ingredients: benzyl alcohol; dibasic sodium phosphate dodecahydrate; monobasic potassium phosphate; water for injections; sodium hydroxide - the solution is designed for injection directly into the lumen of the varicose vein and is used as a sclerosant in the treatment of uncomplicated varicose veins of the leg by compression sclerotherapy. the strength of fibrovein selected depends on the size of the veins to be treated. fibrovein 3% is for the treatment of large superficial varicose veins. fibrovein 1% is for the treatment of small varicose veins and the larger venules. minor venules and spider veins (venous flares) should be treated with fibrovein 0.5% or 0.2%. the selection of the incorrect strength particularly in the case of minor venules and spider veins is liable to give risk to adverse reactions.

Australia - English - Department of Health (Therapeutic Goods Administration)

australasian medical & scientific ltd - sodium tetradecyl sulfate, quantity: 30 mg/ml - injection, solution - excipient ingredients: benzyl alcohol; water for injections; dibasic sodium phosphate dodecahydrate; monobasic potassium phosphate; sodium hydroxide - indications as at 09 june 2005 : the solution is designed for injection directly into the lumen of the varicose vein and is used as a sclerosant in the treatment of uncomplicated varicose veins of the leg by compression sclerotherapy. the strength of fibrovein selected depends on the size of the veins to be treated. fibrovein 3% is for the treatment of large superficial varicose veins. fibrovein 1% is for the treatment of small varicose veins and the larger venules. minor venules and spider veins (venous flares) should be treated with fibrovein 0.5% or 0.2%. the selection of the incorrect strength particularly in the case of minor venules and spider veins is liable to give rise to adverse reactions.